Takeda Pharmaceutical Co., Ltd. (4502)

3,794.0 +65.0 (+1.74%)
Delayed Data JPY Disclaimer

4502 Financial Summary

For the fiscal year ended 31 March 2022, Takeda Pharmaceutical Co Ltd revenues increased 12% to Y3.569T. Net income decreased 39% to Y230.06B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Research and development expenses increase of 15% to Y526.09B (expense), Amortization and Impairment Losses on Pr increase of 12% to Y472.92B (expense).
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
4502
Gross margin TTM 68.99%
Operating margin TTM 12.91%
Net Profit margin TTM 6.45%
Return on Investment TTM 2.08%
Total Revenue
Net Income
Title
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Total Revenue 873,289 901,294 844,819 949,603
Gross Profit 564,909 619,890 569,022 708,339
Operating Income -1,619 116,484 97,427 248,552
Net Income -11,358 57,769 45,964 137,683
Clear All
0Selected
Please try another search
4502
Quick Ratio MRQ 0.81
Current Ratio MRQ 1.21
LT Debt to Equity MRQ 72.87%
Total Debt to Equity MRQ 76.46%
Total Assets
Total Liabilities
Title
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Total Assets 13,178,018 12,698,519 12,560,273 12,657,234
Total Liabilities 7,494,999 7,367,190 7,236,338 7,418,976
Total Equity 5,683,019 5,331,329 5,323,935 5,238,258
Clear All
0Selected
Please try another search
4502
Cash Flow/Share TTM 517.74
Revenue/Share TTM 2,271.94
Operating Cash Flow 52.34%
Cash
Net Change in Cash
Title
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Cash From Operating Activities 1,123,105 747,521 400,011 166,858
Cash From Investing Activities -198,125 -172,487 -103,349 -70,445
Cash From Financing Activities -1,070,265 -826,465 -658,405 -411,038
Net Change in Cash -116,527 -241,882 -358,341 -311,301
Clear All
0Selected
Please try another search

* In Millions of JPY (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.